Seeing Is Believing
Healthcare - Sector
BEAM is currently covered by 8 analysts with an average price target of $46.5. This is a potential upside of $22.61 (100.26%) from yesterday's end of day stock price of $23.22.
Beam Therapeutics 's activity chart (see below) currently has 120 price targets and 114 ratings on display. The stock rating distribution of BEAM is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 43.17% with an average time for these price targets to be met of 91.83 days.
Highest price target for BEAM is $80, Lowest price target is $26, average price target is $46.5.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH. First documented stock forecast 02-Mar-2020.
Currently out of the existing stock ratings of BEAM, 8 are a BUY (80%), 2 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2020
$65
$41.01 (170.95%)
$65
Buy Since 13-Dec-2022
$68
$33.19 (95.35%)
$56
5 months 20 days ago
(26-Mar-2026)
0/3 (0%)
$44.38 (187.89%)
Hold Since 04-May-2021
$26
$-8.81 (-25.31%)
$20
6 months 21 days ago
(25-Feb-2026)
8/8 (100%)
$-3.61 (-12.19%)
22
Buy Since 11-Mar-2025
$41
$6.19 (17.78%)
$32
7 months 25 days ago
(21-Jan-2026)
3/7 (42.86%)
$9.88 (31.75%)
253
Hold Since 25-Feb-2025
$28
$-6.81 (-19.56%)
$30
8 months 8 days ago
(07-Jan-2026)
4/4 (100%)
$-0.93 (-3.21%)
133
What is BEAM (Beam Therapeutics ) average time for price targets to be met?
Which analyst most recently updated their price target on BEAM (Beam Therapeutics )?
Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?
Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?
Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?